UBS Maintains Neutral on CME Group, Raises Price Target to $270
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice TargetHot
UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $260 to $270.
UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $260 to $270.